UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

The lancet oncology, 2016-08, Vol.17 (8), p.1047-1060

2016

Volltextzugriff (PDF)

Exploring the choices and outcomes of older patients with advanced kidney disease

PloS one, 2020-06, Vol.15 (6), p.e0234309-e0234309

2020

Volltextzugriff (PDF)

Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status

Sexual medicine, 2022-02, Vol.10 (1), p.100465-100465, Article 100465

2022

Volltextzugriff (PDF)

Psychosexual morbidity in women with ovarian cancer

International journal of gynecological cancer, 2020-12, Vol.30 (12), p.1983-1989

2020

Volltextzugriff (PDF)

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

The New England journal of medicine, 2011-10, Vol.365 (15), p.1396-1405

2011

Volltextzugriff (PDF)

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

The lancet oncology, 2022-10, Vol.23 (10), p.1308-1320

2022

Volltextzugriff (PDF)

Frailty and comorbidity are independent predictors of outcome in patients referred for pre-dialysis education

Clinical kidney journal, 2016-04, Vol.9 (2), p.324-329

2016

Volltextzugriff (PDF)

International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial

BJU international, 2024-02, Vol.133 (2), p.179-187

2024

Volltextzugriff (PDF)

10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.304-304

2023

Volltextzugriff (PDF)

PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.298-298

2023

Volltextzugriff (PDF)

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial

International journal of gynecological cancer, 2024-07, Vol.34 (7), p.1034-1040

2024

Volltextzugriff (PDF)

Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.325-325

2020

Volltextzugriff (PDF)

Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: Report of 220 tumors and review of literature

Genes chromosomes & cancer, 2008-01, Vol.47 (1), p.34-42

2008

Volltextzugriff (PDF)

Sexual effects of cancer: women and people born with female reproductive organs

Nursing times (1987), 2024-03, Vol.120 (3), p.34-38

2024

Volltextzugriff (PDF)

Land-use and land-cover change carbon emissions between 1901 and 2012 constrained by biomass observations

Biogeosciences, 2017-11, Vol.14 (22), p.5053-5067

2017

Volltextzugriff (PDF)

Large potential for crop production adaptation depends on available future varieties

Global change biology, 2021-08, Vol.27 (16), p.3870-3882

2021

Volltextzugriff (PDF)

Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition

Journal of clinical oncology, 2017-04, Vol.35 (11), p.1240-1249

2017

Volltextzugriff (PDF)

Photoreceptor Layer Thickness Changes During Dark Adaptation Observed With Ultrahigh-Resolution Optical Coherence Tomography

Investigative ophthalmology & visual science, 2017-09, Vol.58 (11), p.4632-4643

2017

Volltextzugriff (PDF)

Are Land-Use Change Emissions in Southeast Asia Decreasing or Increasing?

Global biogeochemical cycles, 2022-01, Vol.36 (1), p.n/a

2022

Volltextzugriff (PDF)

High ambitions for net carbon neutral

Physics world, 2020-06, Vol.33 (6), p.25-26

2020

Volltextzugriff (PDF)

Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort

Dementia and geriatric cognitive disorders, 2018-01, Vol.45 (3-4), p.232

2018

Volltextzugriff (PDF)

Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors

Genome medicine, 2018-10, Vol.10 (1), p.81-81, Article 81

2018

Volltextzugriff (PDF)

Prediction of acute myeloid leukaemia risk in healthy individuals

Nature (London), 2018-07, Vol.559 (7714), p.400-404

2018

Volltextzugriff (PDF)

The DEAD-box helicase DDX56 is a conserved stemness regulator in normal and cancer stem cells

Cell reports (Cambridge), 2021-03, Vol.34 (13), p.108903-108903, Article 108903

2021

Volltextzugriff (PDF)

Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra

Cancer research (Chicago, Ill.), 2017-01, Vol.77 (2), p.509-519

2017

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(55)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Exploring the choices and outcomes of older patients with advanced kidney disease

Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status

Psychosexual morbidity in women with ovarian cancer

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Frailty and comorbidity are independent predictors of outcome in patients referred for pre-dialysis education

International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trial

10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016)

PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis

Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial

Eight-year outcomes of a phase III randomized trial of conventional versus hypofractionated high-dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): Update from the CHHiP Trial

Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: Report of 220 tumors and review of literature

Sexual effects of cancer: women and people born with female reproductive organs

Land-use and land-cover change carbon emissions between 1901 and 2012 constrained by biomass observations

Large potential for crop production adaptation depends on available future varieties

Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition

Photoreceptor Layer Thickness Changes During Dark Adaptation Observed With Ultrahigh-Resolution Optical Coherence Tomography

Are Land-Use Change Emissions in Southeast Asia Decreasing or Increasing?

High ambitions for net carbon neutral

Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort

Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors

Prediction of acute myeloid leukaemia risk in healthy individuals

The DEAD-box helicase DDX56 is a conserved stemness regulator in normal and cancer stem cells

Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra

Suchergebnisse filtern